GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹2.09 Cr |
| Mar2024 | ₹4,561 Cr |
| Mar2023 | ₹-528 Cr |
| Mar2022 | ₹-333 Cr |
| Mar2021 | ₹-675 Cr |
How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.09 Cr | -99.95 | |
| Mar2024 | ₹4,561 Cr | Positive | |
| Mar2023 | ₹-528 Cr | Negative | |
| Mar2022 | ₹-333 Cr | Negative | |
| Mar2021 | ₹-675 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,176.1 Cr | -1.4% | 2.2% | 32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.4% |
2.2% |
32.1% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses